Skip to main content
. 2012 Jun;93(3):172–178. doi: 10.1111/j.1365-2613.2012.00814.x

Table 4.

Incidence and severity of histopathological lesions in the testes, epididymis and prostate glands of BOL-treated groups; B = 4.4 mg/kg bwt BOL treated, C = 8.8 mg/kg bwt BOL treated

Incidence* and Severity of Histopathological Lesions

Group B Group C


Organ/Lesion Absent (−) Mild (+) Moderate (++) Severe (+++) Absent (−) Mild (+) Moderate (++) Severe (+++)
Testes
 Small disorganized tubules with thickened irregular basement membrane 1 3 6 0 0 0 2 8
 Vacuolation of germ cells and Sertoli cells 3 1 3 3 0 0 4 6
 Sloughing germ cells 0 2 3 5 0 1 3 6
 Giant cell formations 3 1 6 0 5 3 2 0
 Reduced spermatogenesis 0 1 5 4 0 0 1 9
 Coagulative necrosis of tubules 6 4 0 0 3 7 0 0
 Interstitial fibrosis 8 2 0 0 0 2 2 6
Epididymis
 Sloughing germ cells 0 2 4 4 0 2 3 5
 Low sperm density 0 1 5 4 0 0 1 9
Prostate
 Tubular dilatation 8 0 2 0 6 0 4 0
*

Number of rabbits with lesions per total examined (10 rabbits per group).

Severity of lesions was graded by estimating the percentage area affected in the entire section. Lesion scoring: (−) absence of the lesion = 0%, (+) mild = 5–25%, (++) moderate = 26–50% and (+++) severe ≥50% of the examined tissue sections.